VanEck Uranium+Nuclear Energy ETF(NLR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

NLR VanEck Uranium+Nuclear Energy ETF

Trading 12-27 13:34:58 EST

82.60

-1.01

-1.21%

High83.32	Low81.87	Vol70.71K
Open83.32	D1 Closing83.61	Amplitude1.73%
Mkt Cap761.29M	Tradable Cap761.29M	Total Shares9.22M
T/O5.82M	T/O Rate0.77%	Tradable Shares9.22M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"NLR","market":"US","secType":"STK","nameCN":"VanEck Uranium+Nuclear Energy ETF","latestPrice":82.6,"timestamp":1735324494796,"preClose":83.61,"halted":0,"volume":70709,"delay":0,"floatShares":9216632,"shares":9216632,"eps":0,"marketStatus":"Trading","change":-1.01,"latestTime":"12-27 13:34:58 EST","open":83.315,"high":83.315,"low":81.8718,"amount":5823459.59999,"amplitude":0.017261,"askPrice":82.75,"askSize":100,"bidPrice":82.19,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Market Trading","tradingStatus":3,"beginTime":1735333200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":83.61,"sharesOutstanding":9216632,"nav":83.41461,"aum":768801759.2,"bidAskSpread":0.002594,"preHourTrading":{"tag":"盘前","latestPrice":83.6,"preClose":83.61,"latestTime":"09:23 EST","volume":1861,"amount":155593.33418,"timestamp":1735309420550},"postHourTrading":{"tag":"盘后","latestPrice":83.61,"preClose":83.61,"latestTime":"19:26 EST","volume":252,"amount":21118.86,"timestamp":1735259171679},"volumeRatio":0.505671,"impliedVol":0.2269,"impliedVolPercentile":0.7302},"requestUrl":"/m/hq/s/NLR/wiki","defaultTab":"wiki","newsList":[{"id":"2491322908","title":"BriaCell 2024 SABCS® Poster Highlights Ability of Bria-IMT™ Regimen to Increase Cancer-Fighting Immune Cells in Metastatic Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2491322908","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491322908?lang=en_us&edition=fundamental","pubTime":"2024-12-13 20:50","pubTimestamp":1734094200,"startTime":"0","endTime":"0","summary":"BriaCell reports influx of cancer fighting CD8+ “killer” T cell into metastatic breast cancer tumors and lymph organs turning “Cold” tumors and lymph nodes “Hot” on ImmunoPET imaging in cancer patient","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/13/2996746/0/en/BriaCell-2024-SABCS-Poster-Highlights-Ability-of-Bria-IMT-Regimen-to-Increase-Cancer-Fighting-Immune-Cells-in-Metastatic-Breast-Cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NLR","BK4139","ABIL","CPI","BCTX"],"gpt_icon":0},{"id":"2490212859","title":"BriaCell Presents Unprecedented Overall Survival Data in Metastatic Breast Cancer in Spotlight Poster at 2024 SABCS®","url":"https://stock-news.laohu8.com/highlight/detail?id=2490212859","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490212859?lang=en_us&edition=fundamental","pubTime":"2024-12-11 20:50","pubTimestamp":1733921400,"startTime":"0","endTime":"0","summary":"Median overall survival (OS) to date of 13.4 months for Phase 2 patients treated with the Phase 3 formulation (15.6 months for those treated since 2022), double that of comparable patients in the lite","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/11/2995320/0/en/BriaCell-Presents-Unprecedented-Overall-Survival-Data-in-Metastatic-Breast-Cancer-in-Spotlight-Poster-at-2024-SABCS.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBC","BK4135","CNS","OS","CPI","NLR","BK4086","BK4097","DTH"],"gpt_icon":0},{"id":"2489445629","title":"South Korea ETFs struggle despite country showing 'resiliency' after martial law","url":"https://stock-news.laohu8.com/highlight/detail?id=2489445629","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489445629?lang=en_us&edition=fundamental","pubTime":"2024-12-06 07:57","pubTimestamp":1733443020,"startTime":"0","endTime":"0","summary":"Investors are also watching France after its government fell this week. This week's ETF Wrap looks at what the recent political turmoil in South Korea and France means for investors.\"The response from both government and civil society\" showed South Korea's \"checks and balances and strength of institutions are strong,\" said Perth Tolle, founder of Life + Liberty Indexes, in an email to MarketWatch. Tolle's Freedom 100 Emerging Markets ETF FRDM - which tracks an index of emerging-market stocks based on personal- and economic-freedom metrics and excludes authoritarian regimes - currently has a 14% weight to South Korea.\"Our methodology results in higher exposure to countries with stronger institutions, rule of law, and checks and balances,\" said Tolle. South Korea provided \"a good test of all those things, and so far, the outcome appears consistent with their allocation in the FRDM index strategy,\" she said, referring to the ticker of the Freedom 100 Emerging Markets ETF.Shares of the fun","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["US10Y.BOND","RAYE","BK4550","BK4585","MFSB","ARKG","SCY","MFSG","ARKK","MKOR","CORO","US6M.BOND","US7Y.BOND","QQLV","US5Y.BOND","MFSV","US30Y.BOND","US3Y.BOND","BK4535","EWQ","MFSM","EWY","PFXF","BK4588","NLR","ARKF","SMH","YGLD","MFSI","OIH","FLKR","MOO","US12M.BOND","ARKW","US2Y.BOND","EMLC","QBIG","FRDM","BK4544","FDN"],"gpt_icon":1},{"id":"2489940754","title":"What a new uranium-trading platform says about investor interest in nuclear energy","url":"https://stock-news.laohu8.com/highlight/detail?id=2489940754","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489940754?lang=en_us&edition=fundamental","pubTime":"2024-12-06 03:47","pubTimestamp":1733428020,"startTime":"0","endTime":"0","summary":"There's 'clearly a lot of interest in uranium among investors, and this includes retail investors': analyst. Investor interest in nuclear energy is running hot and leading to new products, including the launch this week of a blockchain-based platform that allows traders to buy and sell a tokenized version of uranium.There's \"clearly a lot of interest in uranium among investors, and this includes retail investors,\" said Jonathan Hinze, president at UxC, a nuclear-fuel market information and analysis firm. \"With the outlook for nuclear power and fuel demand growth continuously improving, it's no surprise that investors want to capture the upside potential in this market.\". Still, liquidity and ease of trading on the new platform will be key to its success for investors, he told MarketWatch.\"The appetite for nuclear power is definitely increasing, so there's an uptrend to catch here in terms of interest for and visibility of the assets,\" said Arthur Breitman, co-founder of Tezos, an open-","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4156","LU1599440770.SGD","LU2506951958.HKD","LU2506951792.HKD","LU0950375773.USD","YLLXF","LU2023251221.USD","LU2357125470.USD","LU2506951875.HKD","CME","BK4585","LU2237438978.USD","BK4566","IE00BVYPNW00.USD","IE00BGHQF631.EUR","LU0823414551.USD","LU0823417653.USD","LU2506952170.USD","IE00BDGV0183.EUR","IE00B3PB1722.GBP","LU0795875169.SGD","IE00BVYPNV92.GBP","LU2294711713.HKD","LU2089284900.SGD","LU0795875086.SGD","LU2347655156.SGD","LU2133065610.SGD","LU2249611893.SGD","IE00B3T34201.USD","CCJ","LU0912757837.SGD","LU0731783394.SGD","LU0823417737.USD","LU0823414478.USD","LU0158827948.USD","BK4591","BK4561","LU2506952097.USD","URA","BK4563","IE00B42XCP33.USD","LU2089283258.USD","BK4112","BK4104","UROY","LU1718418525.SGD","NLR","LU1732800096.USD","LU1732799900.SGD"],"gpt_icon":0},{"id":"2485230494","title":"VanEck Uranium And Nuclear ETF: I Don't Like The Composition","url":"https://stock-news.laohu8.com/highlight/detail?id=2485230494","media":"seekingalpha","labels":["analysis"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485230494?lang=en_us&edition=fundamental","pubTime":"2024-11-22 18:10","pubTimestamp":1732270219,"startTime":"0","endTime":"0","summary":"During the 28th COP28 Summit, something remarkable happened: Twenty countries have decided to triple their nuclear power production by 2050.The ETF has a high concentration in utilities and lacks sign","market":"sh","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1556635801/image_1556635801.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1556635801/image_1556635801.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4739534-vaneck-uranium-nuclear-etf-i-dont-like-composition","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"analysis","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["NLR"],"gpt_icon":0},{"id":"2483813255","title":"Uranium prices rise after Russia temporarily limits supplies to U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2483813255","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483813255?lang=en_us&edition=fundamental","pubTime":"2024-11-16 01:32","pubTimestamp":1731691939,"startTime":"0","endTime":"0","summary":"zhongguo/E+ via Getty Images Uranium prices rose Friday after Russia announced temporary restrictions on the export of enriched uranium to the U.S., although uranium-related shares trade mixed after moving higher on the initial news. Trading higher: Ur-Energy (URG) +3.6%, Denison Mines (","market":"sg","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1185889689/image_1185889689.jpg?io=getty-c-w750","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1185889689/image_1185889689.jpg?io=getty-c-w750"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4295795-uranium-prices-rise-after-russia-temporarily-limits-supplies-to-us","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_trending_news","symbols":["BK4588","BK4156","BK4585","NLR","URA","URG","UEC"],"gpt_icon":0},{"id":"2483061988","title":"Biden administration unveils plan to triple nuclear energy capacity by 2050","url":"https://stock-news.laohu8.com/highlight/detail?id=2483061988","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483061988?lang=en_us&edition=fundamental","pubTime":"2024-11-13 06:43","pubTimestamp":1731451421,"startTime":"0","endTime":"0","summary":"vchal/iStock via Getty Images The Biden administration announced plans Tuesday to triple U.S. nuclear energy capacity by 2050 as it aims to reach its net-zero emissions goal. Under the plan, the U.S. would deploy an additional 200 GW of new nuclear energy capacity by 2050 through","market":"nz","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1270632735/image_1270632735.jpg?io=getty-c-w750","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1270632735/image_1270632735.jpg?io=getty-c-w750"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4282612-biden-administration-unveils-plan-to-triple-nuclear-energy-capacity-by-2050","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_trending_news","symbols":["URA","BK4585","NLR","BK4588"],"gpt_icon":0},{"id":"2482789558","title":"Indaptus Therapeutics’ Pioneering Research on Novel Immunotherapy Approach Published in Peer-Reviewed Frontiers in Immunology","url":"https://stock-news.laohu8.com/highlight/detail?id=2482789558","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482789558?lang=en_us&edition=fundamental","pubTime":"2024-11-11 21:00","pubTimestamp":1731330000,"startTime":"0","endTime":"0","summary":"Preclinical data demonstrates Decoy platform single agent anti-tumor activity and combination-mediated tumor eradication with NSAID, anti-PD1 checkpoint therapy, low dose chemotherapy (LDC) and/or tar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/11/2978250/0/en/Indaptus-Therapeutics-Pioneering-Research-on-Novel-Immunotherapy-Approach-Published-in-Peer-Reviewed-Frontiers-in-Immunology.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LENZ","NLR"],"gpt_icon":0},{"id":"2481904186","title":"Indaptus Therapeutics Presents Encouraging Interim Safety Data from Phase 1 Clinical Trial of Decoy20 at the Society for Immunotherapy of Cancer (SITC) 2024 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2481904186","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481904186?lang=en_us&edition=fundamental","pubTime":"2024-11-07 21:00","pubTimestamp":1730984400,"startTime":"0","endTime":"0","summary":"Data further confirms Company’s “Pulse-Prime” hypothesis. NEW YORK, Nov. 07, 2024  -- Indaptus Therapeutics, Inc.  , a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, announces compelling safety, pharmacokinetics, and biomarker data on its lead compound, Decoy20, at the Society for Immunotherapy of Cancer  2024 annual meeting. The data derive from two cohorts  of Decoy20 single administration and one cohort  of Decoy20 weekly administration in the Company’s ongoing Phase 1 clinical trial. The SITC conference is being held November 6-10, 2024 in Houston, Tex.Indaptus Therapeutics has evolved from more than a century of immunotherapy advances. The Company’s novel approach is based on the hypothesis that efficient activation of both innate and adaptive immune cells and pathways and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system-activating signals that can be adminis","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/3XXQS3YWdGJ1JC2JJgEReg--~B/aD02MDt3PTIyNjthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/7ccb73735e7b3453e7f55361e2fdf8ed","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/3XXQS3YWdGJ1JC2JJgEReg--~B/aD02MDt3PTIyNjthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/7ccb73735e7b3453e7f55361e2fdf8ed"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/indaptus-therapeutics-presents-encouraging-interim-130000687.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["INDP","SITC","NLR","LENZ","BK4080","BK4231","BK4139"],"gpt_icon":0},{"id":"2479701989","title":"NLR: A Strategic Play In The Nuclear Energy Resurgence","url":"https://stock-news.laohu8.com/highlight/detail?id=2479701989","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479701989?lang=en_us&edition=fundamental","pubTime":"2024-10-31 17:48","pubTimestamp":1730368119,"startTime":"0","endTime":"0","summary":"Editor's note: Seeking Alpha is proud to welcome Matthew Doherty as a new contributing analyst. You can become one too! Share your best investment idea by submitting your article for review to our editors. Get published, earn money, and unlock exclusive SA Premium access.","market":"hk","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/496672575/image_496672575.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/496672575/image_496672575.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4731356-nlr-strategic-play-nuclear-energy-resurgence","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_fund","symbols":["NLR"],"gpt_icon":0},{"id":"2478807433","title":"Centrus Energy, other nuclear stocks extend powerful rally","url":"https://stock-news.laohu8.com/highlight/detail?id=2478807433","media":"seekingalpha","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478807433?lang=en_us&edition=fundamental","pubTime":"2024-10-28 22:57","pubTimestamp":1730127427,"startTime":"0","endTime":"0","summary":"vchal/iStock via Getty Images Several nuclear-related stocks start the week with big gains, extending continued momentum following recent investments by Amazon Web Services and Google into nuclear ene","market":"us","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1270632735/image_1270632735.jpg?io=getty-c-w750","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1270632735/image_1270632735.jpg?io=getty-c-w750"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4213910-centrus-energy-other-nuclear-stocks-extend-powerful-rally","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_trending_news","symbols":["NLR","LEU","NNE","LTBR","AMZN","BK7129","OKLO","BK4081","URNM.AU","BK4182","SMR","BK4156","BK4563","URNM","BK4585","BK7083","URA","BK4588"],"gpt_icon":1},{"id":"2477564550","title":"Celestica Announces Third Quarter 2024 Financial Results and Will Host Virtual Investor Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2477564550","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477564550?lang=en_us&edition=fundamental","pubTime":"2024-10-24 04:15","pubTimestamp":1729714500,"startTime":"0","endTime":"0","summary":"Q3 2024 revenue and non-IFRS adjusted EPS* exceed the high end of guidance ranges;2024 full-year outlook raised and 2025 outlook provided(All amounts in U.S. dollars. Per share information based on di","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/23/2968205/0/en/Celestica-Announces-Third-Quarter-2024-Financial-Results-and-Will-Host-Virtual-Investor-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NLR","BK4539","LU2045819591.USD","ATS","IAS","BK4009","NYSE","LU0128526141.USD","LU0029874061.USD","HST","BK4181","CLS","CCS","BK4088","BK4161","BK4126","TRS","BK4588","BK4145","BK4218","BK4585","SBC","LU2125910500.SGD","BK4196"],"gpt_icon":0},{"id":"2477551274","title":"U.S. big tech stocks are driving the nuclear energy momentum – SG","url":"https://stock-news.laohu8.com/highlight/detail?id=2477551274","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477551274?lang=en_us&edition=fundamental","pubTime":"2024-10-24 01:22","pubTimestamp":1729704163,"startTime":"0","endTime":"0","summary":"BanksPhotos/E+ via Getty Images Many big U.S. technology stocks  have announced new investments in nuclear energy and partnerships for power security, as the rise of artificial intelligence is driving secular electricity demand in the U.S. Almost all hyper-scalers are focused on energy security","market":"other","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/155380595/image_155380595.jpg?io=getty-c-w750","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/155380595/image_155380595.jpg?io=getty-c-w750"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4196593-us-big-tech-stocks-are-driving-the-nuclear-energy-momentum-sg","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_trending_news","symbols":["NUKZ","NLR","BK4588","IYW","SG","BK4209","BK4585"],"gpt_icon":0},{"id":"2477558356","title":"Societe Generale’s global nuclear-exposed picks as capacity increases","url":"https://stock-news.laohu8.com/highlight/detail?id=2477558356","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477558356?lang=en_us&edition=fundamental","pubTime":"2024-10-23 23:34","pubTimestamp":1729697666,"startTime":"0","endTime":"0","summary":"zhongguo/E+ via Getty Images Global nuclear energy capacity is expected to accelerate this decade, generating investment opportunities in stocks that are exposed to the sector, according to Societe Generale analysts. The International Energy Agency’s Net Zero Emissions by 2050 plan’s most feasible, cost-effective, and socially acceptable","market":"sh","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1185889689/image_1185889689.jpg?io=getty-c-w750","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1185889689/image_1185889689.jpg?io=getty-c-w750"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4196030-societe-generales-global-nuclear-exposed-picks-as-capacity-increases","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_trending_news","symbols":["NLR"],"gpt_icon":0},{"id":"2477387823","title":"NLR: Nuclear Boom Doesn't Trickle Down Much To Utility Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2477387823","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477387823?lang=en_us&edition=fundamental","pubTime":"2024-10-22 20:00","pubTimestamp":1729598402,"startTime":"0","endTime":"0","summary":"visual7/E+ via Getty Images The VanEck Uranium and Nuclear Energy ETF (NYSEARCA:NLR) is a pretty broad utilities ETF focused on companies with significant generation from nuclear capacity, but also some stocks with positive exposure to Uranium prices. Nuclear in","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4728200-nlr-nuclear-boom-doesnt-trickle-down-much-to-utility-shareholders","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_fund","symbols":["FDN","BK4588","BK4585","NLR","BK4550"],"gpt_icon":0},{"id":"2477335593","title":"Indaptus Therapeutics Announces Clinical Supply Agreement with BeiGene to Evaluate Novel Cancer Treatment Combinations","url":"https://stock-news.laohu8.com/highlight/detail?id=2477335593","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477335593?lang=en_us&edition=fundamental","pubTime":"2024-10-22 20:00","pubTimestamp":1729598400,"startTime":"0","endTime":"0","summary":"Planned industry first clinical trial combining BeiGene's checkpoint inhibitor tislelizumab with Indaptus’ broadly targeted, short duration systemic immune stimulator Decoy20 expected to start in 2025","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/22/2966888/0/en/Indaptus-Therapeutics-Announces-Clinical-Supply-Agreement-with-BeiGene-to-Evaluate-Novel-Cancer-Treatment-Combinations.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LENZ","06160","NLR","BGNE"],"gpt_icon":0},{"id":"2476466015","title":"Nuclear-energy ETFs surge as uranium prices remain rangebound. Is now a good time to invest?","url":"https://stock-news.laohu8.com/highlight/detail?id=2476466015","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2476466015?lang=en_us&edition=fundamental","pubTime":"2024-10-18 07:33","pubTimestamp":1729207980,"startTime":"0","endTime":"0","summary":"Rising electricity demand related to AI and shrinking supply suggest uranium prices could bounce above $107 a pound, says one analyst. This is MarketWatch reporter Isabel Wang, bringing you this week's ETF Wrap. In this edition, we look at uranium and nuclear-energy ETFs, which have soared this month as technology giants are seeking new sources of carbon-free electricity to meet the surging power demand of data centers that train and run artificial-intelligence applications.The VanEck Uranium and Nuclear ETF NLR has advanced 13.2% so far in October, on track to score it best month since April 2009. The Global X Uranium ETF URA is up 14.5% in the same period, with the $4 billion fund on pace to log its best month in over a year, according to FactSet data.While nuclear-energy ETFs are seeing a heyday, uranium - the heavy metal widely used for nuclear power generation, has lost some of its luster this month. Uranium's spot price has risen a modest 2.7% in October to trade at $83.95 per po","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09042","IE00B7KXQ091.USD","HODL","NLR","BTC.USD.CC","USO","83042","LU0170899867.USD","SCO","UCO","GOOGL","KMID","IE0004086264.USD","LU0130102774.USD","BK4577","03008","BTGD","09439","BK4559","NATKY","TSLY","URNM","LU0130517989.USD","03439","BTC","UNG","AMZN","03042","IE00BFSS8Q28.SGD","MSFT","09008","D","CQQQ","FBTC","BTC.USD.HKCC","IE00B1BXHZ80.USD","RSMC","LU0130103400.USD","CONY","FDN","URA","LU0096364046.USD","LU0149725797.USD","GOOG","CEG","LU1093756168.USD","IE00BJTD4V19.USD","BK4587"],"gpt_icon":1},{"id":"2475850939","title":"SeaStar Medical to Showcase New Mechanistic Data Highlighting the Immunomodulatory Effect of the Selective Cytopheretic Device in Acute Kidney Injury at ASN Kidney Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2475850939","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2475850939?lang=en_us&edition=fundamental","pubTime":"2024-10-15 20:30","pubTimestamp":1728995400,"startTime":"0","endTime":"0","summary":"DENVER, Oct.  15, 2024  (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/15/2963207/0/en/SeaStar-Medical-to-Showcase-New-Mechanistic-Data-Highlighting-the-Immunomodulatory-Effect-of-the-Selective-Cytopheretic-Device-in-Acute-Kidney-Injury-at-ASN-Kidney-Week.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NLR","SCD"],"gpt_icon":0},{"id":"2475508754","title":"Indaptus Therapeutics Initiates Unrestricted Enrollment of Patients on Decoy20 Weekly Dosing Based on Encouraging Safety Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2475508754","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2475508754?lang=en_us&edition=fundamental","pubTime":"2024-10-15 20:00","pubTimestamp":1728993600,"startTime":"0","endTime":"0","summary":"NEW YORK, Oct.  15, 2024  (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical stage biotechnology company dedicated to pioneering innovative cancer","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/15/2963142/0/en/Indaptus-Therapeutics-Initiates-Unrestricted-Enrollment-of-Patients-on-Decoy20-Weekly-Dosing-Based-on-Encouraging-Safety-Data.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NLR","LENZ"],"gpt_icon":0},{"id":"2474142277","title":"Indaptus Therapeutics Founder and Chief Scientific Officer to Speak on Lumanity Webinar about the Future of Innate Immunity in Cancer Immunotherapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2474142277","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474142277?lang=en_us&edition=fundamental","pubTime":"2024-10-10 20:00","pubTimestamp":1728561600,"startTime":"0","endTime":"0","summary":"NEW YORK, Oct.  10, 2024  (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical-stage biotechnology company dedicated to developing novel treatments for cancer and viral infection","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/10/2961260/0/en/Indaptus-Therapeutics-Founder-and-Chief-Scientific-Officer-to-Speak-on-Lumanity-Webinar-about-the-Future-of-Innate-Immunity-in-Cancer-Immunotherapy.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NLR","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vaneck.com/etf/equity/nlr/overview/","stockEarnings":[{"period":"1week","weight":0.0112},{"period":"1month","weight":-0.1118},{"period":"3month","weight":-0.0144},{"period":"6month","weight":0.0455},{"period":"1year","weight":0.156},{"period":"ytd","weight":0.1658}],"compareEarnings":[{"period":"1week","weight":0.026},{"period":"1month","weight":0.0011},{"period":"3month","weight":0.0523},{"period":"6month","weight":0.105},{"period":"1year","weight":0.262},{"period":"ytd","weight":0.2652}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes equity securities and depositary receipts issued by companies involved in uranium and nuclear energy. The fund is non-diversified.","yearOnYearQuotes":[{"month":1,"riseRate":0.588235,"avgChangeRate":0.006065},{"month":2,"riseRate":0.529412,"avgChangeRate":-0.007755},{"month":3,"riseRate":0.647059,"avgChangeRate":-0.002173},{"month":4,"riseRate":0.588235,"avgChangeRate":0.020604},{"month":5,"riseRate":0.588235,"avgChangeRate":0.011482},{"month":6,"riseRate":0.352941,"avgChangeRate":-0.016852},{"month":7,"riseRate":0.588235,"avgChangeRate":-0.027672},{"month":8,"riseRate":0.529412,"avgChangeRate":-0.009523},{"month":9,"riseRate":0.555556,"avgChangeRate":-0.002172},{"month":10,"riseRate":0.611111,"avgChangeRate":0.011139},{"month":11,"riseRate":0.611111,"avgChangeRate":0.002819},{"month":12,"riseRate":0.444444,"avgChangeRate":-0.022291}],"exchange":"ARCA","name":"VanEck Uranium+Nuclear Energy ETF","nameEN":"VanEck Uranium+Nuclear Energy ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"VanEck Uranium+Nuclear Energy ETF(NLR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest VanEck Uranium+Nuclear Energy ETF(NLR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"VanEck Uranium+Nuclear Energy ETF,NLR,VanEck Uranium+Nuclear Energy ETF股票,VanEck Uranium+Nuclear Energy ETF股票老虎,VanEck Uranium+Nuclear Energy ETF股票老虎国际,VanEck Uranium+Nuclear Energy ETF行情,VanEck Uranium+Nuclear Energy ETF股票行情,VanEck Uranium+Nuclear Energy ETF股价,VanEck Uranium+Nuclear Energy ETF股市,VanEck Uranium+Nuclear Energy ETF股票价格,VanEck Uranium+Nuclear Energy ETF股票交易,VanEck Uranium+Nuclear Energy ETF股票购买,VanEck Uranium+Nuclear Energy ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"VanEck Uranium+Nuclear Energy ETF(NLR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest VanEck Uranium+Nuclear Energy ETF(NLR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction